Ciba/B-ORG -/I-ORG Geigy/I-ORG AG/I-ORG ,/O the/O big/O Swiss/O chemicals/O company/O ,/O said/O that/O it/O agreed/O in/O a/O letter/O of/O intent/O with/O Corning/B-ORG Inc./I-ORG to/O acquire/O Corning/B-ORG 's/O 50/O %/O share/O of/O Ciba/B-ORG Corning/I-ORG Diagnostics/I-ORG Corp./I-ORG ,/O based/O in/O Medfield/B-GPE ,/O Mass/B-GPE ./O
Ciba/B-ORG Corning/I-ORG ,/O which/O had/O been/O a/O 50/O -/O 50/O venture/O between/O Basel/B-GPE -/O based/O Ciba/B-ORG -/I-ORG Geigy/I-ORG and/O Corning/B-ORG ,/O has/O annual/O sales/O of/O about/O $/O 300/O million/O ,/O the/O announcement/O said/O ./O
Terms/O of/O the/O transaction/O were/O n't/O disclosed/O ./O
Ciba/B-ORG Corning/I-ORG makes/O clinical/O diagnostics/O systems/O and/O related/O products/O for/O the/O medical/O -/O care/O industry/O ./O
The/O announcement/O said/O the/O acquisition/O should/O be/O completed/O by/O December/O after/O a/O definitive/O agreement/O is/O completed/O and/O regulatory/O approval/O is/O received/O ./O
Ciba/B-ORG -/I-ORG Geigy/I-ORG intends/O to/O develop/O the/O Ciba/B-ORG Corning/I-ORG unit/O into/O a/O ``/O substantial/O business/O ,/O ''/O making/O the/O unit/O an/O ``/O integral/O part/O ''/O of/O Ciba/B-ORG -/I-ORG Geigy/I-ORG 's/I-ORG ``/O comprehensive/O disease/O management/O concept/O ./O
